{"id":499978,"date":"2021-06-02T08:24:54","date_gmt":"2021-06-02T12:24:54","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/poseida-therapeutics-announces-virtual-2021-annual-meeting-of-stockholders\/"},"modified":"2021-06-02T08:24:54","modified_gmt":"2021-06-02T12:24:54","slug":"poseida-therapeutics-announces-virtual-2021-annual-meeting-of-stockholders","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/poseida-therapeutics-announces-virtual-2021-annual-meeting-of-stockholders\/","title":{"rendered":"Poseida Therapeutics Announces Virtual 2021 Annual Meeting of Stockholders"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">SAN DIEGO<\/span>, <span class=\"xn-chron\">June 2, 2021<\/span> \/PRNewswire\/ &#8212; Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell and gene therapeutics with the capacity to cure, today announced that its Annual Meeting of Stockholders (the &#8220;Annual Meeting&#8221;) will be held virtually via live webcast on <span class=\"xn-chron\">Wednesday, June 16, 2021<\/span> at <span class=\"xn-chron\">1:00pm PT<\/span>.\u00a0 Stockholders of record at the close of business on <span class=\"xn-chron\">April 20, 2021<\/span>, are entitled to vote in the Annual Meeting.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/1023018\/Poseida_Therapeutics_Logo.html\" target=\"_blank\" rel=\"nofollow noopener\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/1023018\/Poseida_Therapeutics_Logo.jpg\" title=\"Poseida Therapeutics (PRNewsfoto\/Poseida Therapeutics, Inc.)\" alt=\"Poseida Therapeutics (PRNewsfoto\/Poseida Therapeutics, Inc.)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>As provided in the Company&#8217;s proxy materials, an online portal is available to stockholders at <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3182335-1&amp;h=3442428531&amp;u=https%3A%2F%2Fwww.proxydocs.com%2FPSTX&amp;a=https%3A%2F%2Fwww.proxydocs.com%2FPSTX\" rel=\"nofollow noopener\">https:\/\/www.proxydocs.com\/PSTX<\/a> where stockholders can view and download the Company&#8217;s proxy materials and 2020 Annual Report and vote their shares in advance of the Annual Meeting. Stockholders may also submit questions and vote their shares prior to the Annual Meeting by following the instructions available on the Annual Meeting website.<\/p>\n<p>To be admitted to the Annual Meeting, stockholders must register at <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3182335-1&amp;h=3442428531&amp;u=https%3A%2F%2Fwww.proxydocs.com%2FPSTX&amp;a=https%3A%2F%2Fwww.proxydocs.com%2FPSTX\" rel=\"nofollow noopener\">https:\/\/www.proxydocs.com\/PSTX<\/a> by <span class=\"xn-chron\">8:00pm PT<\/span>, on <span class=\"xn-chron\">June 14, 2021<\/span>. To register, stockholders must enter their control number found in the proxy materials sent to stockholders. Poseida encourages stockholders to access the Annual Meeting prior to the start time in order to allow ample time for check-in procedures.<\/p>\n<p>Below are additional details on how stockholders can participate in the virtual Annual Meeting:<\/p>\n<ul type=\"disc\">\n<li>Access the meeting platform beginning at <span class=\"xn-chron\">12:45pm PT<\/span> on <span class=\"xn-chron\">June 16, 2021<\/span>. <\/li>\n<li>Vote during the Annual Meeting by following the instructions available on the Annual Meeting website. <\/li>\n<li>Submit a question in advance of the meeting by visiting the Annual Meeting website and entering the stockholder&#8217;s control number.<\/li>\n<\/ul>\n<p>Whether or not a stockholder plans to attend the virtual-only Annual Meeting, Poseida Therapeutics urges each stockholder to vote and submit their proxy in advance of the meeting by one of the methods described in the proxy materials.<\/p>\n<p>\n        <b>About Poseida Therapeutics, Inc.<br \/><\/b>Poseida Therapeutics is a clinical-stage biopharmaceutical company dedicated to utilizing our proprietary genetic engineering platform technologies to create next generation cell and gene therapeutics with the capacity to cure. We have discovered and are developing a broad portfolio of product candidates in a variety of indications based on our core proprietary platforms, including our non-viral piggyBac<sup>\u00ae<\/sup> DNA Delivery System, Cas-CLOVER\u2122 site-specific gene editing system and nanoparticle- and AAV-based gene delivery technologies. Our core platform technologies have utility, either alone or in combination, across many cell and gene therapeutic modalities and enable us to engineer our wholly-owned portfolio of product candidates that are designed to overcome the primary limitations of current generation cell and gene therapeutics. To learn more, visit <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3182335-1&amp;h=2864978806&amp;u=http%3A%2F%2Fwww.poseida.com%2F&amp;a=www.poseida.com\" rel=\"nofollow noopener\">www.poseida.com<\/a> and connect with us on <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3182335-1&amp;h=3297013087&amp;u=https%3A%2F%2Ftwitter.com%2FPoseidaThera&amp;a=Twitter\" rel=\"nofollow noopener\">Twitter<\/a> and <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3182335-1&amp;h=618597746&amp;u=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fposeida-therapeutics-inc-%2F&amp;a=LinkedIn\" rel=\"nofollow noopener\">LinkedIn<\/a>.<\/p>\n<p>\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=LA96818&amp;sd=2021-06-02\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"http:\/\/www.prnewswire.com\/news-releases\/poseida-therapeutics-announces-virtual-2021-annual-meeting-of-stockholders-301303379.html\">http:\/\/www.prnewswire.com\/news-releases\/poseida-therapeutics-announces-virtual-2021-annual-meeting-of-stockholders-301303379.html<\/a><\/p>\n<p>SOURCE  Poseida Therapeutics, Inc.<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=LA96818&amp;Transmission_Id=202106020800PR_NEWS_USPR_____LA96818&amp;DateId=20210602\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire SAN DIEGO, June 2, 2021 \/PRNewswire\/ &#8212; Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell and gene therapeutics with the capacity to cure, today announced that its Annual Meeting of Stockholders (the &#8220;Annual Meeting&#8221;) will be held virtually via live webcast on Wednesday, June 16, 2021 at 1:00pm PT.\u00a0 Stockholders of record at the close of business on April 20, 2021, are entitled to vote in the Annual Meeting. As provided in the Company&#8217;s proxy materials, an online portal is available to stockholders at https:\/\/www.proxydocs.com\/PSTX where stockholders can view and download the Company&#8217;s proxy materials and 2020 Annual Report and vote their shares in advance of the Annual &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/poseida-therapeutics-announces-virtual-2021-annual-meeting-of-stockholders\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Poseida Therapeutics Announces Virtual 2021 Annual Meeting of Stockholders&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-499978","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Poseida Therapeutics Announces Virtual 2021 Annual Meeting of Stockholders - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/poseida-therapeutics-announces-virtual-2021-annual-meeting-of-stockholders\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Poseida Therapeutics Announces Virtual 2021 Annual Meeting of Stockholders - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire SAN DIEGO, June 2, 2021 \/PRNewswire\/ &#8212; Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell and gene therapeutics with the capacity to cure, today announced that its Annual Meeting of Stockholders (the &#8220;Annual Meeting&#8221;) will be held virtually via live webcast on Wednesday, June 16, 2021 at 1:00pm PT.\u00a0 Stockholders of record at the close of business on April 20, 2021, are entitled to vote in the Annual Meeting. As provided in the Company&#8217;s proxy materials, an online portal is available to stockholders at https:\/\/www.proxydocs.com\/PSTX where stockholders can view and download the Company&#8217;s proxy materials and 2020 Annual Report and vote their shares in advance of the Annual &hellip; Continue reading &quot;Poseida Therapeutics Announces Virtual 2021 Annual Meeting of Stockholders&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/poseida-therapeutics-announces-virtual-2021-annual-meeting-of-stockholders\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-02T12:24:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1023018\/Poseida_Therapeutics_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/poseida-therapeutics-announces-virtual-2021-annual-meeting-of-stockholders\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/poseida-therapeutics-announces-virtual-2021-annual-meeting-of-stockholders\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Poseida Therapeutics Announces Virtual 2021 Annual Meeting of Stockholders\",\"datePublished\":\"2021-06-02T12:24:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/poseida-therapeutics-announces-virtual-2021-annual-meeting-of-stockholders\\\/\"},\"wordCount\":458,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/poseida-therapeutics-announces-virtual-2021-annual-meeting-of-stockholders\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1023018\\\/Poseida_Therapeutics_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/poseida-therapeutics-announces-virtual-2021-annual-meeting-of-stockholders\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/poseida-therapeutics-announces-virtual-2021-annual-meeting-of-stockholders\\\/\",\"name\":\"Poseida Therapeutics Announces Virtual 2021 Annual Meeting of Stockholders - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/poseida-therapeutics-announces-virtual-2021-annual-meeting-of-stockholders\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/poseida-therapeutics-announces-virtual-2021-annual-meeting-of-stockholders\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1023018\\\/Poseida_Therapeutics_Logo.jpg\",\"datePublished\":\"2021-06-02T12:24:54+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/poseida-therapeutics-announces-virtual-2021-annual-meeting-of-stockholders\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/poseida-therapeutics-announces-virtual-2021-annual-meeting-of-stockholders\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/poseida-therapeutics-announces-virtual-2021-annual-meeting-of-stockholders\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1023018\\\/Poseida_Therapeutics_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1023018\\\/Poseida_Therapeutics_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/poseida-therapeutics-announces-virtual-2021-annual-meeting-of-stockholders\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Poseida Therapeutics Announces Virtual 2021 Annual Meeting of Stockholders\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Poseida Therapeutics Announces Virtual 2021 Annual Meeting of Stockholders - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/poseida-therapeutics-announces-virtual-2021-annual-meeting-of-stockholders\/","og_locale":"en_US","og_type":"article","og_title":"Poseida Therapeutics Announces Virtual 2021 Annual Meeting of Stockholders - Market Newsdesk","og_description":"PR Newswire SAN DIEGO, June 2, 2021 \/PRNewswire\/ &#8212; Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell and gene therapeutics with the capacity to cure, today announced that its Annual Meeting of Stockholders (the &#8220;Annual Meeting&#8221;) will be held virtually via live webcast on Wednesday, June 16, 2021 at 1:00pm PT.\u00a0 Stockholders of record at the close of business on April 20, 2021, are entitled to vote in the Annual Meeting. As provided in the Company&#8217;s proxy materials, an online portal is available to stockholders at https:\/\/www.proxydocs.com\/PSTX where stockholders can view and download the Company&#8217;s proxy materials and 2020 Annual Report and vote their shares in advance of the Annual &hellip; Continue reading \"Poseida Therapeutics Announces Virtual 2021 Annual Meeting of Stockholders\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/poseida-therapeutics-announces-virtual-2021-annual-meeting-of-stockholders\/","og_site_name":"Market Newsdesk","article_published_time":"2021-06-02T12:24:54+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1023018\/Poseida_Therapeutics_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/poseida-therapeutics-announces-virtual-2021-annual-meeting-of-stockholders\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/poseida-therapeutics-announces-virtual-2021-annual-meeting-of-stockholders\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Poseida Therapeutics Announces Virtual 2021 Annual Meeting of Stockholders","datePublished":"2021-06-02T12:24:54+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/poseida-therapeutics-announces-virtual-2021-annual-meeting-of-stockholders\/"},"wordCount":458,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/poseida-therapeutics-announces-virtual-2021-annual-meeting-of-stockholders\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1023018\/Poseida_Therapeutics_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/poseida-therapeutics-announces-virtual-2021-annual-meeting-of-stockholders\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/poseida-therapeutics-announces-virtual-2021-annual-meeting-of-stockholders\/","name":"Poseida Therapeutics Announces Virtual 2021 Annual Meeting of Stockholders - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/poseida-therapeutics-announces-virtual-2021-annual-meeting-of-stockholders\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/poseida-therapeutics-announces-virtual-2021-annual-meeting-of-stockholders\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1023018\/Poseida_Therapeutics_Logo.jpg","datePublished":"2021-06-02T12:24:54+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/poseida-therapeutics-announces-virtual-2021-annual-meeting-of-stockholders\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/poseida-therapeutics-announces-virtual-2021-annual-meeting-of-stockholders\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/poseida-therapeutics-announces-virtual-2021-annual-meeting-of-stockholders\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1023018\/Poseida_Therapeutics_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1023018\/Poseida_Therapeutics_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/poseida-therapeutics-announces-virtual-2021-annual-meeting-of-stockholders\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Poseida Therapeutics Announces Virtual 2021 Annual Meeting of Stockholders"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/499978","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=499978"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/499978\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=499978"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=499978"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=499978"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}